Oral Transmucosal Drug Delivery

NEW YORK, May 31, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Oral Transmucosal Drug Delivery

http://www.reportlinker.com/p0870772/Oral-Transmucosal-Drug-Delivery.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

In their search for alternative delivery methods that will enhance compliance and improve safety, drug developers and researchers are discovering that the permeability of mucous membranes provides a convenient route for the systemic delivery of new and existing therapeutic drugs. Transmucosal delivery offers the potential for once daily dosing of oral drugs and avoids the effects of first pass metabolism. On the provider side, the development of alternative methods of drug administration has improved the ability of physicians to manage specific problems. Practitioners now recognize the rapid onset, relative reliability, and the general lack of patient discomfort when drugs are administered by the transmucosal route. We expect this market to experience healthy growth through 2015 as buccal technology is applied to existing drugs and as transmucosal formulations become an important route of administration for an increasing number of new NCEs. Growth in this sector will also be driven by the pressure to extend market protection for numerous existing drugs with soon-to-expire patents.

Highlights

Analyzes and evaluates oral transmucosal drug delivery technology platforms and their impact on the market

Analyzes oral transmucosal drug products and pipeline product candidates

Provides assessments of key oral transmucosal drug therapeutic categories

Provides market data and forecasts to 2016

Profiles market participants, their product development activities and strategies

Read more:
Oral Transmucosal Drug Delivery